EMEA-001129-PIP01-11-M06 - paediatric investigation plan

peginterferon beta-1a

Key facts

• Invented name:
  Plegridy
• Active Substance:
  peginterferon beta-1a
• Therapeutic area:
  Neurology
• Decision number:
  P/0419/2023
• PIP number:
  EMEA-001129-PIP01-11-M06
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of multiple sclerosis
• Route(s) of administration:
  • Subcutaneous use
  • Intramuscular use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  25/10/2023

Decision

P/0419/2023 : EMA decision of 25 October 2023 on the acceptance of a modification of an agreed paediatric investigation plan for peginterferon beta-1a (Plegridy), (EMEA-001129-PIP01-11-M06)

AdoptedReference Number: EMA/469210/2023